tiprankstipranks
Neuroscientific Biopharmaceuticals Ltd. (AU:NSB)
ASX:NSB
Australian Market
Want to see AU:NSB full AI Analyst Report?

Neuroscientific Biopharmaceuticals Ltd. (NSB) Financial Statements

9 Followers

Neuroscientific Biopharmaceuticals Ltd. Financial Overview

Neuroscientific Biopharmaceuticals Ltd.'s market cap is currently AU$24.16M. The company's EPS TTM is AU$-0.0151; its P/E ratio is -4.39; Neuroscientific Biopharmaceuticals Ltd. is scheduled to report earnings on August 27, 2026, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 26Jun 25Jun 24Jun 23Jun 22
Income Statement
Total RevenueAU$ 0.00AU$ 0.00AU$ 2.21MAU$ 4.95MAU$ 0.00
Gross ProfitAU$ -1.38MAU$ -92.78KAU$ -91.34KAU$ -57.85KAU$ -64.92K
Operating IncomeAU$ -5.11MAU$ -1.92MAU$ -2.06MAU$ -6.12MAU$ -10.50M
EBITDAAU$ -3.72MAU$ -1.92MAU$ -1.80MAU$ -5.96MAU$ -10.37M
Net IncomeAU$ -4.69MAU$ -1.85MAU$ 324.21KAU$ -1.07MAU$ -10.44M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 4.63MAU$ 7.27MAU$ 4.95MAU$ 4.91MAU$ 7.22M
Total AssetsAU$ 15.18MAU$ 16.96MAU$ 5.44MAU$ 5.29MAU$ 7.74M
Total DebtAU$ 87.04KAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Net DebtAU$ -2.54MAU$ -7.27MAU$ -4.95MAU$ -4.91MAU$ -7.22M
Total LiabilitiesAU$ 374.89KAU$ 149.22KAU$ 85.68KAU$ 597.36KAU$ 2.22M
Stockholders' EquityAU$ 14.81MAU$ 16.81MAU$ 5.35MAU$ 4.69MAU$ 5.52M
Cash Flow
Free Cash FlowAU$ 0.00AU$ -941.33KAU$ 42.43KAU$ -2.30MAU$ -6.95M
Operating Cash FlowAU$ -2.61MAU$ -941.33KAU$ 44.25KAU$ -2.30MAU$ -6.94M
Investing Cash FlowAU$ -2.00MAU$ -36.04KAU$ -1.81KAU$ 0.00AU$ -3.87K
Financing Cash FlowAU$ -30.26KAU$ 3.29MAU$ 0.00AU$ 0.00AU$ 0.00
Currency in AUD

Neuroscientific Biopharmaceuticals Ltd. Earnings and Revenue History

Neuroscientific Biopharmaceuticals Ltd. Debt to Assets

Neuroscientific Biopharmaceuticals Ltd. Cash Flow

Neuroscientific Biopharmaceuticals Ltd. Forecast EPS vs Actual EPS